Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1

CEND-1 (iRGD) is a bifunctional cyclic peptide that can modulate the solid tumour microenvironment, enhancing the delivery and therapeutic index of co-administered anti-cancer agents. This study explored CEND-1’s pharmacokinetic (PK) properties pre-clinically and clinically, and assessed CEND-1 dist...

Descripción completa

Detalles Bibliográficos
Autores principales: Järveläinen, Harri A., Schmithals, Christian, von Harten, Maike, Kakoschky, Bianca, Vogl, Thomas J., Harris, Stephen, Henson, Claire, Bullen-Clerkson, Gemma, Piiper, Albrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053770/
https://www.ncbi.nlm.nih.gov/pubmed/36982773
http://dx.doi.org/10.3390/ijms24065700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053770/
https://www.ncbi.nlm.nih.gov/pubmed/36982773
http://dx.doi.org/10.3390/ijms24065700

Ejemplares similares